Lifeward

Lifeward CapEx/OCF

The CapEx to Operating Cash Flow Ratio of Lifeward (LFWD) as of Nov 22, 2026 is -0.10 %.

CapEx/OCF

-0.10 %

Last updated:

CapEx to Operating Cash Flow Ratio of Lifeward is 2025 -0.10 % . CapEx to Operating Cash Flow Ratio of Lifeward was 2024 0.00 . It decreases by % lower compared to the previous year.

The Lifeward CapEx/OCF history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

CapEx/OCF
Date
CapEx/OCF
Jan 1, 2018
-0.09 USD
Jan 1, 2019
-0.15 USD
Jan 1, 2020
-0.58 USD
Jan 1, 2021
-0.41 USD
Jan 1, 2022
-0.14 USD
Jan 1, 2023
-0.39 USD
Jan 1, 2024
0.00 USD
Jan 1, 2025
-0.10 USD
The Lifeward CapEx/OCF history
YEARCapEx/OCFYoY
-0.10 %—
0.00-100.00%
-0.39 %+180.48%
-0.14 %-65.90%
-0.41 %-29.33%
-0.58 %+290.49%
-0.15 %+68.76%
-0.09 %-5.73%
-0.09 %-94.31%
-1.64 %-29.23%
-2.32 %+110.23%
-1.10 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Lifeward Stock analysis

What does Lifeward do? Rewalk Robotics Ltd is a publicly traded company specializing in the development and manufacture of exoskeletons that enable individuals with spinal injuries or paralysis to regain mobility. It was founded in 2001 and is based in Marlborough, Massachusetts. The company's goal is to provide individuals with mobility impairments the opportunity for greater freedom of movement and improved quality of life. Rewalk Robotics has launched various products in the field of rehabilitation and industrial applications, and it continues to research and develop new applications for its technology. The exoskeletons use a combination of motors, sensors, and control systems to allow users to stand, walk, and even climb stairs. In addition to medical applications, Rewalk Robotics also provides exoskeletons for industrial use, enhancing worker safety and productivity. The company is actively involved in research and development to expand the therapeutic possibilities of exoskeletons for neurologic conditions such as stroke and Parkinson's disease. Rewalk Robotics is dedicated to innovation and technology, aiming to improve the lives of millions worldwide by providing greater mobility and autonomy. Lifeward is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Lifeward stock

CapEx to Operating Cash Flow Ratio of Lifeward is -0.10 % in 2025.

On Eulerpool you can find the complete historical development of CapEx to Operating Cash Flow Ratio Lifeward since 2006 – with annual values, charts, and detailed analysis.

The CapEx/OCF ratio shows what percentage of operating cash flow is reinvested in capital assets. Lower ratios indicate more free cash available for shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare CapEx to Operating Cash Flow Ratio's Lifeward with sector peers and the industry average to assess whether it is attractive.

To evaluate CapEx to Operating Cash Flow Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for CapEx to Operating Cash Flow Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Lifeward

All Key Metrics — Lifeward